Your browser doesn't support javascript.
loading
Factor associated with failure to administer subsequent treatment after progression in the first-line chemotherapy in EGFR-mutant non-small cell lung cancer: Okayama Lung Cancer Study Group experience.
Kato, Yuka; Hotta, Katsuyuki; Takigawa, Nagio; Nogami, Naoyuki; Kozuki, Toshiyuki; Sato, Akiko; Ichihara, Eiki; Kudo, Kenichiro; Oze, Isao; Tabata, Masahiro; Shinkai, Tetsu; Tanimoto, Mitsune; Kiura, Katsuyuki.
Affiliation
  • Kato Y; Department of Respiratory Medicine, Okayama University Hospital, 2-5-1, Shikata-cho, Kitaku, Okayama, 700-8558, Japan.
Cancer Chemother Pharmacol ; 73(5): 943-50, 2014 May.
Article in En | MEDLINE | ID: mdl-24633759
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Drug Therapy / ErbB Receptors / Lung Neoplasms / Antineoplastic Agents Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2014 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Drug Therapy / ErbB Receptors / Lung Neoplasms / Antineoplastic Agents Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2014 Document type: Article Affiliation country: Country of publication: